Page last updated: 2024-11-12

azietomidate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

azietomidate: a photolabel for gated ion channels; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9971904
CHEMBL ID23812
SCHEMBL ID1044050
MeSH IDM0448802

Synonyms (7)

Synonym
2-(3-methyldiazirin-3-yl)ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
azietomidate
CHEMBL23812 ,
gtpl5404
2-(3-methyl-3h-diazirin-3-yl)ethyl 1-(1-phenylethyl)-1h-imidazole-5-carboxylate
[3h]azietomidate
SCHEMBL1044050

Research Excerpts

Overview

Azietomidate is a photoreactive analog of the general anesthetic etomidate. It acts as a nicotinic acetylcholine receptor (nAChR) noncompetitive antagonist.

ExcerptReferenceRelevance
"Azietomidate is a photoreactive analog of the general anesthetic etomidate that acts as a nicotinic acetylcholine receptor (nAChR) noncompetitive antagonist. "( Time-resolved photolabeling of the nicotinic acetylcholine receptor by [3H]azietomidate, an open-state inhibitor.
Arevalo, E; Chiara, DC; Cohen, JB; Forman, SA; Hong, FH; Husain, SS; Miller, KW, 2009
)
2.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID21134Solubility in 0.05 M Tris-HCl buffer, pH 7.42003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.
AID147713Inhibition of recombinant embryonic mouse muscle Nicotinic Acetylcholine Receptor (3 oocytes)2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.
AID269959Enhancement of [3H]flunitrazepam binding to cerebral cortex GABA-A receptor at >=0.3 uM2006Journal of medicinal chemistry, Aug-10, Volume: 49, Issue:16
Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels.
AID269951Anesthetic activity in Xenopus tadpole measured as loss of righting reflex2006Journal of medicinal chemistry, Aug-10, Volume: 49, Issue:16
Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels.
AID269955Inhibition of 5HT3 receptor at 2.2 uM2006Journal of medicinal chemistry, Aug-10, Volume: 49, Issue:16
Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels.
AID269962Reduction of [3H]flunitrazepam binding to cerebral cortex GABA-A receptor at 100 uM relative to control2006Journal of medicinal chemistry, Aug-10, Volume: 49, Issue:16
Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels.
AID21249The octanol/water partition coefficient of [3H]azietomidate2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (88.89)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.95 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]